Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
300 Leser
Artikel bewerten:
(1)

Pacific Health Care Organization, Inc. Reports its Second Quarter 2025 Financial Results

Irvine, July 31, 2025 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the "Company") (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the "SEC") its quarterly report on Form 10-Q announcing its financial results for the quarter ended June 30, 2025.

Results

The Company reported total revenues of $1,726,541 for the quarter ended June 30, 2025, compared to $1,541,087 for the quarter ended June 30, 2024.

The Company reported income from operations of $303,559 for the quarter ended June 30, 2025, compared to income from operations of $191,995 for the quarter ended June 30, 2024.

The Company realized net income of $636,907 or $0.05 per weighted average share outstanding, basic and diluted, for the quarter ended June 30, 2025, compared to net income of $215,556 or $0.02 per weighted average share outstanding, basic and diluted, for the quarter ended June 30, 2024.

Net cash provided by operating activities was $785,838 and $143,648 in the six months ended June 30, 2025 and the six months ended June 30, 2024, respectively, an increase of $642,190.

Net cash used in investing activities was ($664,536) during the six months ended June 30, 2025, and ($181,963) during the six months ended June 30, 2024. The change in net cash used in investing activities was due to the purchase of US Treasury Bills during the second quarter of 2025.

During the six months ended June 30, 2025, net cash used in financing activities was $35,930, compared to $105,915 of cash provided by financing activities during the six months ended June 30, 2024. The change in net cash used in financing activities from period to period was due primarily to the Company's insurance financing agreement entered into during fiscal year 2024, which matured early in fiscal year 2025.

The Company's balance of cash and cash equivalents at June 30, 2025 and December 31, 2024 was $2,155,848 and $2,070,476 respectively.

To better understand the Company's second quarter 2025 financial results, readers should review the Company's quarterly report on Form 10-Q filed with the SEC on July 31, 2025.

About Pacific Health Care Organization, Inc.

The Company specializes in workers' compensation cost containment. The Company's business objective is to deliver value to its customers that reduces their workers' compensation related medical claims expense in a manner that will assure that injured employees receive high quality healthcare that allows them to recover from injury and return to gainful employment without undue delay. Through its wholly owned subsidiaries, the Company provides a range of effective workers' compensation cost containment services, including but not limited to Health Care Organizations, Medical Provider Networks, medical case management, utilization review, medical bill review, workers' compensation carve-outs and Medicare set-aside services. The Company offers its services as a bundled solution, as standalone services, or as add-on services.

"Safe Harbor" Statement: Statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. Forward-looking statements are based on management's current judgment, expectations, estimates, projections, and assumptions about future events. While management believes these assumptions are reasonable, such statements are not guarantees of future results and involve certain risks and uncertainties which are difficult to predict. Therefore, actual results and trends may differ materially from what is forecast in any forward-looking statement due to a variety of factors. Additional information regarding these factors, such as the potential loss of one or more key customers, is contained in the Company's filings with the SEC, including without limitation, its annual reports on Form 10-K and its quarterly reports on Form 10-Q.

All forward-looking statements speak only as of the date they were made. The Company does not undertake any obligation to update or publicly release any revisions to any forward-looking statements to reflect events, circumstances, or changes in expectations after the date of this press release.

To view the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2025, filed with the SEC and the Company's annual, quarterly and current reports and other information the Company files with or furnishes to the SEC go to:?http://www.sec.gov. You may also view the Company's annual reports on Form 10-K and quarterly reports on Form 10-Q on its website at http://www.pacifichealthcareorganization.com.


© 2025 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.